G&S Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

G&S Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$705.89 - $766.39 $396,710 - $430,711	562 New	562 $0
Q4 2020 Jan 21, 2021	SELL	$478.3 - $607.98 $284,588 - $361,748	-595 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$544.75 - $658.21 $54,475 - $65,821	100 Added 20.2%	595 $333,000
Q2 2020 Jul 24, 2020	SELL	$493.32 - $643.92 $57,225 - $74,694	-116 Reduced 18.99%	495 $309,000
Q1 2020 Apr 23, 2020	BUY	$336.18 - $494.43 $205,405 - $302,096	611 New	611 $298,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

Stay updated on G&S Capital LLC with notifications on news.